News
On average, the study showed that Medicare prescription drug plans now cover just 56% of analyzed medications – a steep drop ...
AI empowers marketers to personalize campaigns by analyzing customer behavior and preferences for tailored recommendations ...
Thailand's Transport Ministry plans a mixed-use development at Khlong Toei port, focusing on smart port and community benefits.
The initial POC results, presented April 26, 2025 at the Annual ELITE PED-GI Congress, show crofelemer reduced the required total parenteral nutrition (TPN) and/or supplementary intravenous fluids, ...
In February 2025, Tenaya was awarded an $8.0 million clinical grant from the California Institute for Regenerative Medicine (CIRM), which is expected to help fund clinical trial costs for the ongoing ...
LifeVantage Corporation (NASDAQ: LFVN) Q3 2025 Earnings Call Transcript May 6, 2025 LifeVantage Corporation beats earnings ...
At March 31, 2025, the Company's cash and cash equivalents grew to $938.5 million, compared to $912.8 million at December 31, 2024, after prepaying a $50.0 million deposit related to our Evergreen ...
Crofelemer is the only oral drug approved by the FDA's Center for Drug Evaluation and Research under Botanical GuidanceClick here to access replay of company's April 30, 2025 investor webcast SAN FRAN ...
Here we go again. In 2017 President Donald Trump sent Interior Secretary Ryan Zinke to New Mexico to consider revoking or ...
The university stated that more courses are being considered for cancellation in the fall of 2026 including graduate diplomas ...
13h
The Mobile Rundown on MSNHe Built an AI Study App in School. Now Millions Use It.Esan Durrani launched StudyFetch as a college student to fix broken study tools—now his AI-powered platform helps over a ...
To continue enjoying articles on the People Management website, please register for free or sign in below. CIPD members have access to all articles on the People Management website. If you are already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results